Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Ejhaem|June 19, 2024
Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignanciesKatherine Parks, Kendall Diebold, Donna Salzman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host diseaseRami B Ibrahim, Muneer H Abidi, Simon M Cronin, et al.
Leukemia Research|March 9, 2024
Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemiaGarrett Bourne, Kendall Diebold, Manuel Espinoza-Gutarra, et al.
Blood Cells, Molecules & Diseases|June 30, 2004
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignanciesLaurence J N Cooper, Zaid Al-Kadhimi, David DiGiusto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 24, 2011
Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trialMuneer H Abidi, Nishant Tageja, Lois Ayash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2014
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patientsZaid Al-Kadhimi, Zartash Gul, Wei Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host diseaseDivaya Bhutani, Gregory Dyson, Richard Manasa, et al.
Anticancer Research|August 8, 2009
Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcomaAshkan Lashkari, Warren A Chow, Frances Valdes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 29, 2012
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trialMuneer H Abidi, Rishi Agarwal, Lois Ayash, et al.
Plos One|September 28, 2017
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipientsMohammad S Hossain, Ghada M Kunter, Vicky F El-Najjar, et al.
Pageof 4